From curing cancer to reducing addictions to curtailing concussions, Indiana University researchers are tackling some of our biggest medical challenges in an effort to preserve and enhance human health.
Enhancing the health of Hoosiers and beyond
Improving Hoosier health
Alzheimer's in low-income areas
IU researchers are studying how socioeconomic exposures in mid-to-later-life affect memory decline and Alzheimer’s disease and related dementia risk.
Learn more about IU's work on Alzheimer's
First-ever study identifies women's pleasure techniques
Researchers from the IU School of Medicine and OMGYES have conducted the first-ever, large-scale, nationally representative study focused on women’s techniques for increasing their own sexual pleasure, with findings published in the scientific journal PLOS ONE.Learn more about the research
Cell-based therapies to prevent limb loss
The Indiana Center for Regenerative Medicine and Engineering is at the national forefront in developing treatments that help save the limbs of patients with severe peripheral arterial disease.
Learn more about IU's research on severe PAD
IU School of Medicine associate professor Ryan Relich answers common questions about variants of the SARS-CoV-2 virus.
The survey reveals that three out of four Hoosiers agree that universities have a responsibility to help improve their communities.
The IU Board of Trustees approved a designs for a new admissions plaza at IU Bloomington, as well as other projects.
An IU School of Medicine study sheds light on the biological basis of mood disorders and offers a precision-medicine approach to treatment.
Graduate programs in public and environmental affairs, business, education, and medicine are ranked highly by U.S. News and World Report.
The study's findings will inform science-based decisions about mask use and social distancing for fully vaccinated people.
Contact tracers managed by the Fairbanks School of Public Health at IUPUI are on call 24/7 as part of the NCAA men's basketball tournament.
Get quick updates on the next "Ask Aaron," a deadline for the student advisory board, upcoming webinars for online teaching and more.
IU School of Medicine infectious disease expert Dr. Lana Dbeibo tells us more about the newest COVID-19 vaccine approved for use in the U.S.
The findings could one day lead to new treatment options that reduce long-term damage to babies from in-utero exposure to opioids.